These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8088260)

  • 61. Medical problems concerning the control group.
    Lorenz D; Lorenz WJ; van Kaick G
    RISO Rep; 1973 Jun; (294):169-74. PubMed ID: 4619715
    [No Abstract]   [Full Text] [Related]  

  • 62. The importance of considering trial design when interpreting clinical trial results.
    Reiffel JA
    J Cardiovasc Pharmacol Ther; 2000 Jan; 5(1):17-25. PubMed ID: 10687670
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Proper analysis in clinical trials: how to report and adjust for missing outcome data.
    Joshi M; Royuela A; Zamora J
    BJOG; 2013 Jul; 120(8):915-9. PubMed ID: 23759083
    [No Abstract]   [Full Text] [Related]  

  • 64. [A round table on the methodology of clinical trials. From the design to the meeting of the Oncology Group of the French-speaking members of the Society of Pneumology organized in Brussels 21 September 1990].
    Sculier JP; Trillet V; Paesmans M; Markiewicz E; Lebeau B; Dabouis G; Kleisbauer JP
    Rev Mal Respir; 1992; 9(2):223-6. PubMed ID: 1565837
    [No Abstract]   [Full Text] [Related]  

  • 65. Note on the design of multi-institution three-treatment studies.
    Makuch RW; Simon RM
    Cancer Clin Trials; 1978; 1(4):301-3. PubMed ID: 757147
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Large-scale clinical trials: are they worth the cost?
    Levy RI; Sondik EJ
    Ann N Y Acad Sci; 1982; 382():411-22. PubMed ID: 6805385
    [No Abstract]   [Full Text] [Related]  

  • 67. Early Termination of Acute Stroke Randomized Controlled Trials Published Between 2013 and 2020: A Systematic Review.
    Strong B; Oostema JA; Nikroo N; Hussain M; Reeves MJ
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007995. PubMed ID: 34932376
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Monitoring treatment effects in clinical trials in the FRG.
    Olschewski M; Leibbrand D
    Experientia Suppl; 1982; 41():485-95. PubMed ID: 6958533
    [No Abstract]   [Full Text] [Related]  

  • 69. [Research based on clinical observations].
    Röding H
    Z Exp Chir; 1975; 8(5):313-24. PubMed ID: 1053191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Early stopping rules--clinical perspectives and ethical considerations.
    Baum M; Houghton J; Abrams K
    Stat Med; 1994 Jul 15-30; 13(13-14):1459-69; discussion 1471-2. PubMed ID: 7973225
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Interim analyses, stopping rules and data monitoring in clinical trials in Europe.
    Buyse M
    Stat Med; 1993 Mar; 12(5-6):509-20. PubMed ID: 8493429
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Oncology data management in the UK--BODMA's view. British Oncology Data Managers Association.
    Riley D; Ward L; Young T
    Br J Cancer; 1994 Sep; 70(3):391-4. PubMed ID: 8080719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Therapeutic studies. Provisional evaluation and early termination].
    Köpcke W
    MMW Munch Med Wochenschr; 1982 May; 124(18):441-3. PubMed ID: 6808365
    [No Abstract]   [Full Text] [Related]  

  • 74. Toward vital status sweeps: a case history in sequential monitoring.
    Hallstrom A; McBride R; Moore R
    Stat Med; 1995 Sep; 14(17):1927-31. PubMed ID: 8532985
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [How many patients are needed for a therapeutic trial? Viewpoints of clinical research (author's transl)].
    Uberla KK
    MMW Munch Med Wochenschr; 1982 May; 124(18):437-40. PubMed ID: 6808364
    [No Abstract]   [Full Text] [Related]  

  • 76. Early stopping rules and long-term follow-up in phase III trials.
    Pignon JP; Arriagada R
    Lung Cancer; 1994 Mar; 10 Suppl 1():S151-9. PubMed ID: 8087505
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial.
    Gilpin AM; Holbrook JT; Jabs DA; Meinert CL;
    Control Clin Trials; 2003 Feb; 24(1):92-8. PubMed ID: 12559647
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Statistical interim monitoring of the Cardiac Arrhythmia Suppression Trial.
    Pawitan Y; Hallstrom A
    Stat Med; 1990 Sep; 9(9):1081-90. PubMed ID: 2244080
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Behind closed doors: the data monitoring board in randomized clinical trials.
    Wittes J
    Stat Med; 1993 Mar; 12(5-6):419-24. PubMed ID: 8493420
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Surrogate end points, skepticism, and the CAST study.
    Thompson DF
    Ann Pharmacother; 2002 Jan; 36(1):170-1. PubMed ID: 11816249
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.